Sentinel lymph nodes mapping in ovarian cancer- preliminary results from single cancer center study
In this preliminary study with a small sample size of 29 patients, intraoperative SLN mapping using methylene blue injection demonstrated a high detection rate and promising feasibility and accuracy for identifying lymph node metastases in ovarian cancer.
Authors
- Y. Liu (ORCID: https://orcid.org/0000-0002-6633-9766)
- Mario M. Leitão (ORCID: https://orcid.org/0000-0003-0818-3836)
- Jingde Jia
- Kaiyun Qin
- Hongxia Wang (ORCID: https://orcid.org/0000-0001-8779-1201)
- Weijian Chen (ORCID: https://orcid.org/0000-0002-7383-7173)
- Yu Yu
- Zhengmao Zhang (ORCID: https://orcid.org/0000-0003-4461-4154)
- Yan Ding (ORCID: https://orcid.org/0000-0001-6391-1977)
Institutions
- Hebei Medical University (CN)
- Memorial Sloan Kettering Cancer Center (US)
- Fourth Hospital of Hebei Medical University (CN)
- Hebei General Hospital (CN)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1186/s12905-025-03734-y
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Horizon 2020 Framework Programme